
Can an MDMA Purity Test Kit Support Better Awareness?
The article explores the potential of MDMA purity test kits in raising public awareness and supporting harm reduction.

The article explores the potential of MDMA purity test kits in raising public awareness and supporting harm reduction.
Research suggests that psychedelic drug therapy may address mental health concerns associated with cancer and addiction.
The FDA is expected to approve psilocybin as the first psychedelic therapy soon, detailing important information for patients.
The recent relaxation of rules surrounding MDMA and psilocybin therapy could lead to significant changes in psychedelic research and treatment.
A bipartisan bill in North Carolina aims to fund psychedelic therapy research targeted at PTSD.
A study found that a new psychedelic therapy shows promise for treating postpartum depression.
The FDA has put psilocybin and an MDMA-like drug on a fast track for approval, signaling a significant development in mental health treatment.
The article discusses the FDA's 2024 decision to decline approval for MDMA therapy and the implications for mental health care.
MAPS has submitted a New Drug Application for psychedelic therapy aimed at treating PTSD.
The article discusses the re-emergence of psychedelic-assisted therapies for treating mental health issues.

The article explores the clinical context of psychedelic-assisted therapy in Austin, Texas.
Phase 3 research clinical trial data will determine the potential of psilocybin as a treatment for depression.
Australia has enabled psychiatrists to leave the room during psychedelic therapy with psilocybin, affecting treatment protocols.
The article explores the potential role of psychedelic therapy in end-of-life care.
Louisiana is joining a national initiative to study the efficacy of psychedelic treatments for mental health issues.
This clinical trial focuses on psilocybin, a psychedelic chemical found in certain mushrooms, and its potential benefits for mental health.
The article discusses the rejection of MDMA-assisted therapy for PTSD treatment and the need for effective solutions for new moms facing anxiety or depression.
The FDA has issued finalized guidance to address the unique challenges of psychedelic research and scheduled a hearing on therapeutic uses.
Results from a Phase III trial indicate psilocybin treatments may offer hope for patients who have not benefited from traditional antidepressants.
The article discusses how psychedelic treatments are evolving to fit into modern clinical care for mental health.
The article discusses a successful psilocybin treatment for Alzheimer’s disease, highlighting significant findings in psychedelic therapy.
Howard Steinberg discusses how psychedelics helped him find a new beginning after losing himself in the pursuit of the American dream.
Connecticut's medical program will open access to psychedelic treatments, including psilocybin, to the public starting July 1.
The potential of psilocybin-assisted therapy to address opioid use disorder is examined in the context of recent legal changes.
Researchers hope psilocybin compounds could eventually become part of mainstream treatment for depression.

The article discusses the emerging web3 ecosystem in India and its potential to lead the next cycle of digital financial innovation.
The article explains how psilocybin research targets 5-HT2A receptors with particular specificity.
Research indicates that a single psilocybin trip can provide up to two years of depression relief for cancer patients.
The article explores how Fourth of July celebrations may influence psychedelic experiences.
This article explores the efficacy and safety of psilocybin in treating major depression that is resistant to other therapies.
The article explores luxury wellness retreats that incorporate psychedelic therapy in their offerings.
Psychedelic therapy shows promise for treating PTSD, with recent studies.
This article explores the importance of therapy in establishing a strong foundation for sobriety.
The article discusses how insights gained from psychedelic experiences can become applicable in daily life.

The article explores the impact of generative AI on mental health and discusses societal numbness in the digital age.
A study indicates that students experiencing high distress frequently use AI tools for mental health support.

The article discusses creating accessible and safe psychedelic experiences.

An overview of the top psychedelic rock acts from the 1960s is provided.

The article explores the implications and responsibilities of using AI as a therapeutic tool.
The article discusses the potential effectiveness of psilocybin for treating depression, comparing it to traditional SSRIs.
A study reveals that nearly 5 million veterans have used substances such as magic mushrooms, LSD, or MDMA for various therapeutic purposes.
A meta-analysis of randomized clinical trials shows that psilocybin is effective for treating depression and anxiety with manageable adverse effects.
Results of a small real-world study indicate that psilocybin may be effective for treating resistant depression.
Natural hallucinogens, such as psilocybin, mescaline, and N,N-dimethyltryptamine (DMT), are explored as potential ecological tools instead of mere chemical accidents.
The article discusses recent attention on psychedelic-assisted therapy in relation to the concept of repressed memories after trauma.
The article discusses the effects of a single dose of magic mushrooms on a woman with advanced Alzheimer's, who started talking again after years of silence.
An open-source TypeScript framework is presented, focused on AI agents with memory and trust capabilities.

The article discusses Albert Hofmann, the chemist who discovered LSD and his lifelong quest to rehabilitate its reputation.
ORA Technologies has announced a $2M funding round, totaling their Series A funding to $10M.
The piece outlines the development of ARI MÓBILE AI, a serverless AI infrastructure from Argentina.
Describe what you care about in plain English. MyFeed scans thousands of sources and delivers only what matters to you.
Popular feeds